MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Sionna Therapeutics, Inc. (SION)
Organization & Developments: Sionna Therapeutics
Parents
Sionna Therapeutics, Inc. (SION)
Children
*Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF)
2024: Sionna Closes $182M Series C in Potential Cystic Fibrosis Showdown with Vertex
2025: Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments_ seekingalpha.com
2026: Sionna lays off 46% of workforce in strategic shift after cystic fibrosis trial fail
2026: Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for Vertex
Jumps
Finance & Acquisitions: Sionna Therapeutics
Key People: Sionna Therapeutics